Jason Ronald Krantz, Executive Chairman and 10% owner of Definitive Healthcare Corp. (NASDAQ:DH), filed a Form 4 on November 3, 2026, disclosing a share withholding transaction dated November 1, 2026, in connection with the vesting and settlement of previously reported restricted stock units.

Key Highlights

  • Transaction date: 12,166 shares of Class A Common Stock were disposed of on November 1, 2026, via transaction code F (tax withholding).
  • Price per share: The shares were withheld at $1.12 per share.
  • Direct holdings after transaction: Krantz directly beneficially owns 1,177,106 shares of Class A Common Stock following the reported transaction.
  • Indirect holdings: An additional 450,000 shares are held indirectly in trust by DH Holdings (formerly known as Jason R. Krantz 2009 Trust), of which Krantz is the beneficiary.
  • Purpose of transaction: According to the filing, the withholding satisfied Krantz's tax obligations in connection with the vesting and settlement of previously reported RSUs.
  • Roles disclosed: Krantz is identified in the filing as Director, 10% Owner, and Executive Chairman.

Krantz RSU Vesting Triggers Share Withholding at Definitive Healthcare

According to the Form 4 filing, Jason Ronald Krantz, who serves as Executive Chairman, Director, and 10% Owner of Definitive Healthcare Corp., reported a single non-derivative transaction involving Class A Common Stock on November 1, 2026. The filing describes the transaction as the withholding of 12,166 shares by the issuer to satisfy tax obligations arising from the vesting and settlement of previously reported restricted stock units (RSUs). The shares were withheld at a price of $1.12 each.

Following the reported transaction, the filing states that Krantz directly holds 1,177,106 shares of Class A Common Stock. In addition, the filing discloses an indirect beneficial ownership position of 450,000 shares held in trust by DH Holdings, formerly known as the Jason R. Krantz 2009 Trust, with Krantz identified as the beneficiary of that trust. No derivative securities transactions were reported in Table II of the filing.

The Form 4 was signed by Jonathan Paris as Attorney-in-Fact on November 3, 2026, and was filed on that date. No amendment date was indicated, and the filing was made by one reporting person. The issuer is listed as Definitive Healthcare Corp. with ticker symbol DH on NASDAQ.

What Was Disclosed

The filing disclosed the withholding of 12,166 Class A Common Stock shares at $1.12 per share by Definitive Healthcare Corp. from Executive Chairman Jason Krantz on November 1, 2026, to cover RSU-related tax obligations, leaving him with 1,177,106 shares directly and 450,000 shares held indirectly through trust.